Literature DB >> 10768983

Role of activated protein C in Helicobacter pylori-associated gastritis.

S Oka1, E C Gabazza, Y Taguchi, M Yamaguchi, S Nakashima, K Suzuki, Y Adachi, I Imoto.   

Abstract

The protein C (PC) pathway has recently been suggested to play a role in the regulation of the inflammatory response. To further extend the anti-inflammatory effect of activated PC (APC) in vivo, particularly its biological relevance to human disease, the activity of APC in the mucosa of patients with Helicobacter pylori-associated gastritis and the effect of vacuolating cytotoxin (VacA), cytotoxin-associated antigen (CagA), and H. pylori lipopolysaccharide (LPS) on PC activation were evaluated. This study comprised 35 patients with chronic gastritis. There were 20 patients with and 15 without H. pylori infection. The levels of PC and APC-PC inhibitor (PCI) complex were measured by immunoassays. The level of PC was significantly decreased and the level of APC-PCI complex was significantly increased in biopsy specimens from gastric corpus and antrum in patients with H. pylori-associated gastritis as compared to H. pylori-negative subjects. The concentrations of VacA, CagA, and LPS were significantly correlated with those of the APC-PCI complex in biopsy mucosal specimens from the gastric corpus and antrum. H. pylori LPS, VacA, and CagA induced a dose-dependent activation of PC on the surface of monocytic cells. APC inhibited the secretion of tumor necrosis factor alpha (TNF-alpha) induced by H. pylori LPS. Overall, these results suggest that H. pylori infection is associated with increased APC generation in the gastric mucosa. The inhibitory activity of APC on TNF-alpha secretion may serve to protect H. pylori-induced gastric mucosal damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10768983      PMCID: PMC97498          DOI: 10.1128/IAI.68.5.2863-2869.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Protein C activation following coronary artery occlusion in the in situ porcine heart.

Authors:  T R Snow; M T Deal; D T Dickey; C T Esmon
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

2.  Localization of distinct F2-isoprostanes in human atherosclerotic lesions.

Authors:  D Praticò; L Iuliano; A Mauriello; L Spagnoli; J A Lawson; J Rokach; J Maclouf; F Violi; G A FitzGerald
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study.

Authors:  R W van der Hulst; A van der Ende; F W Dekker; F J Ten Kate; J F Weel; J J Keller; S P Kruizinga; J Dankert; G N Tytgat
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

4.  Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex.

Authors:  H Deguchi; H Takeya; E C Gabazza; J Nishioka; K Suzuki
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

5.  Protein C inhibitor secreted from activated platelets efficiently inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles.

Authors:  J Nishioka; M Ning; T Hayashi; K Suzuki
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

Review 6.  Mucosal chemokines in Helicobacter pylori infection.

Authors:  T Shimoyama; J E Crabtree
Journal:  J Physiol Pharmacol       Date:  1997-09       Impact factor: 3.011

7.  Detoxification of the Helicobacter pylori cytotoxin.

Authors:  R Manetti; P Massari; M Marchetti; C Magagnoli; S Nuti; P Lupetti; P Ghiara; R Rappuoli; J L Telford
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

Review 8.  Helicobacter pylori, inflammation, mucosal damage, and apoptosis: pathogenesis and definition of gastric atrophy.

Authors:  R M Genta
Journal:  Gastroenterology       Date:  1997-12       Impact factor: 22.682

Review 9.  Helicobacter pylori factors associated with disease development.

Authors:  H L Mobley
Journal:  Gastroenterology       Date:  1997-12       Impact factor: 22.682

10.  Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production.

Authors:  K Murakami; K Okajima; M Uchiba; M Johno; T Nakagaki; H Okabe; K Takatsuki
Journal:  Am J Physiol       Date:  1997-02
View more
  2 in total

1.  Drotrecogin alfa (activated) prevents smoke-induced increases in pulmonary microvascular permeability and proinflammatory cytokine IL-1beta in rats.

Authors:  S S Wong; N N Sun; J D Hyde; L Ruiz; E Meigs; B R Herrin; C D Fastje; S J Macdonald; M L Witten
Journal:  Lung       Date:  2004       Impact factor: 2.584

2.  A new type of intrabacterial nanotransportation system for VacA in Helicobacter pylori.

Authors:  Hong Wu; Takashi Nakano; Yuji Matsuzaki; Yukimasa Ooi; Takehiro Kohno; Sonoko Ishihara; Kouichi Sano
Journal:  Med Mol Morphol       Date:  2014-01-14       Impact factor: 2.309

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.